Ventyx Biosciences, Inc.
NASDAQ:VTYX
2.15 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 51.579 | 64.819 | 70.791 | 0.244 | 0.309 |
| Short Term Investments
| 200.641 | 253.122 | 187.785 | 0 | 0 |
| Cash and Short Term Investments
| 252.22 | 356.613 | 286.724 | 0.244 | 0.309 |
| Net Receivables
| 0.8 | 0 | 0 | 0 | 0 |
| Inventory
| -0.8 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 12.125 | 12.747 | 4.444 | 0.001 | 0.04 |
| Total Current Assets
| 264.345 | 330.688 | 263.02 | 0.245 | 0.349 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 12.271 | 1.944 | 0.254 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| -3.456 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.975 | 38.672 | 28.148 | 0 | 0 |
| Tax Assets
| 2.481 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.077 | 0.096 | 0.06 | 0 | 0 |
| Total Non-Current Assets
| 13.348 | 40.712 | 28.462 | 0 | 0 |
| Total Assets
| 277.693 | 371.4 | 291.482 | 0.245 | 0.349 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 5.756 | 6.433 | 4.661 | 1.102 | 0.362 |
| Short Term Debt
| 1.001 | 0.412 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 15.508 | 9.514 | 7.622 | 0.301 | 0.269 |
| Total Current Liabilities
| 22.265 | 16.359 | 12.283 | 1.403 | 0.631 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 11.505 | 1.146 | 0 | 12.647 | 3.846 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.481 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -2.481 | -0 | 0 | 16.849 | 0 |
| Total Non-Current Liabilities
| 11.505 | 1.146 | 0 | 29.496 | 3.846 |
| Total Liabilities
| 33.77 | 17.505 | 12.283 | 30.899 | 4.477 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.005 | 0 | 0 |
| Retained Earnings
| -419.187 | -226.225 | -117.799 | -32.501 | -4.327 |
| Accumulated Other Comprehensive Income/Loss
| -0.05 | -1.123 | -0.058 | 0 | 0 |
| Other Total Stockholders Equity
| 663.154 | 1.117 | 0.053 | 1.847 | 0.199 |
| Total Shareholders Equity
| 243.923 | -226.225 | -117.799 | -30.654 | -4.128 |
| Total Equity
| 243.923 | -226.225 | -117.799 | -30.654 | -4.128 |
| Total Liabilities & Shareholders Equity
| 277.693 | -208.72 | -105.516 | 0.245 | 0.349 |